Shanghai Sanyou Medical Co., Ltd (SHA:688085)
China · Delayed Price · Currency is CNY 13.70
+0.33 (2.47%)
Sep 4, 2026, 3:00 PM CST
Shanghai Sanyou Medical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5,025 | 6,009 | 5,265 | 4,845 | 6,268 | 6,339 | |
Market Cap Growth | -36.81% | 14.14% | 8.67% | -22.70% | -1.12% | -20.36% |
Enterprise Value | 4,535 | 5,517 | 4,870 | 4,297 | 5,639 | 5,649 |
Last Close Price | 13.70 | 16.36 | 16.03 | 14.69 | 18.95 | 19.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 89.85 | 95.23 | 459.06 | 50.69 | 32.85 | 34.01 |
Forward PE | 49.41 | 47.29 | 37.26 | 32.84 | 24.82 | 31.66 |
PS Ratio | 8.86 | 11.07 | 11.61 | 10.52 | 9.65 | 10.68 |
PB Ratio | 2.33 | 2.83 | 2.57 | 2.37 | 3.28 | 3.65 |
P/TBV Ratio | 2.95 | 3.62 | 3.56 | 3.20 | 4.22 | 4.74 |
P/FCF Ratio | 100.27 | 153.77 | - | 20.06 | 352.58 | 119.02 |
P/OCF Ratio | 59.76 | 88.38 | 480.16 | 18.12 | 40.19 | 43.74 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 8.00 | 10.16 | 10.74 | 9.33 | 8.69 | 9.52 |
EV/EBITDA Ratio | 57.67 | 69.03 | 129.29 | 33.73 | 29.89 | 36.70 |
EV/EBIT Ratio | 103.05 | 111.17 | 816.52 | 42.31 | 32.54 | 40.14 |
EV/FCF Ratio | 90.48 | 141.19 | - | 17.80 | 317.18 | 106.06 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 |
Debt / EBITDA Ratio | 0.45 | 0.48 | 1.06 | 0.04 | 0.03 | 0.03 |
Debt / FCF Ratio | 0.70 | 1.06 | - | 0.02 | 0.30 | 0.10 |
Net Debt / Equity Ratio | -0.23 | -0.35 | -0.31 | -0.33 | -0.28 | -0.43 |
Net Debt / EBITDA Ratio | -6.75 | -9.26 | -17.02 | -5.25 | -2.80 | -4.90 |
Net Debt / FCF Ratio | -10.07 | -18.93 | 24.22 | -2.77 | -29.71 | -14.15 |
Asset Turnover | 0.24 | 0.23 | 0.20 | 0.21 | 0.31 | 0.32 |
Inventory Turnover | 0.54 | 0.59 | 0.69 | 0.63 | 0.52 | 0.59 |
Quick Ratio | 3.03 | 3.85 | 3.40 | 3.79 | 3.31 | 4.32 |
Current Ratio | 5.53 | 5.16 | 4.60 | 4.87 | 4.06 | 4.90 |
Return on Equity (ROE) | 1.54% | 2.15% | 0.59% | 5.75% | 11.16% | 11.93% |
Return on Assets (ROA) | 1.17% | 1.32% | 0.16% | 2.85% | 5.17% | 4.79% |
Return on Invested Capital (ROIC) | 2.29% | 2.89% | 0.24% | 6.21% | 12.44% | 18.39% |
Return on Capital Employed (ROCE) | 2.00% | 2.30% | 0.30% | 4.90% | 8.90% | 8.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.08% | 1.05% | 0.22% | 1.97% | 3.04% | 2.94% |
FCF Yield | 1.00% | 0.65% | -0.50% | 4.98% | 0.28% | 0.84% |
Dividend Yield | 0.13% | 0.11% | 0.02% | 0.40% | 0.31% | 0.60% |
Payout Ratio | 14.96% | 3.39% | 197.50% | 20.09% | 19.58% | 19.24% |
Buyback Yield / Dilution | 8.25% | -15.96% | 5.10% | -1.49% | -0.33% | -8.46% |
Total Shareholder Return | 8.38% | -15.86% | 5.12% | -1.08% | -0.02% | -7.87% |